Evogene (EVGN) Misses Q4 EPS by 20c

Evogene (NASDAQ: EVGN) reported Q4 EPS of ($0.61), $0.20 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $2.28 million versus the consensus estimate of $650 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Johnson Controls (JCI) 4K contracts of August 120 puts trade, share price down 4%
• Backblaze (BLZE) call put ratio 12.9 calls to 1 put with a focus on July 12.50 calls as share price up 40%